Stress at work very unlikely to cause cancer

Researchers conclude that the meta-analysis provided “no evidence for an association between job strain and overall cancer risk” suggesting that work-related psychological stress is unlikely to be an important factor for cancer. And although reducing work stress would improve the well-being of the general population, it is unlikely to have a marked impact on cancer burden at population-level.

###

Research: Work stress and risk of cancer: meta-analysis of 5700 incident cancer events in 116000 European men and women.

Does Stress Feed Cancer?
A little stress can do us good - it pushes us to compete and innovate. But chronic stress can increase the risk of diseases such as depression, heart disease and even cancer. Studies have shown that stress might promote cancer indirectly by weakening the immune system’s anti-tumor defense or by encouraging new tumor-feeding blood vessels to form. But a new study published April 12 in The Journal of Clinical Investigation shows that stress hormones, such as adrenaline, can directly support tumor growth and spread.

For normal cells to thrive in the body, “they need to be attached to their neighbors and their surroundings,” says the study’s lead author Anil Sood from The University of Texas M. D, Anderson Cancer Center in Houston. Cells that detach from their environment undergo a form of programmed cell death called anoikis. “But cancer cells have come up with way to bypass this effect - they avoid anoikis,” Sood says. This allows cancer cells to break off from tumors, spread throughout the body (in blood or other fluid) and form new tumors at distant sites - a process called metastasis. So Sood wondered: Could stress affect anoikis? “It surprised us that this biology hadn’t been studied before,” he notes. “Stress influences so many normal physiological processes. Why wouldn’t it be involved in tumor progression?”

Sood and his team first studied the effects of stress hormones on human ovarian cancer cell anoikis in culture. Cells that were exposed to stress hormones were protected from self destruction - meaning they could survive without being anchored to their surroundings. The stress hormone treatment activated a protein called FAK (focal adhesion kinase), which is known to protect cells from anoikis. Inhibiting FAK reversed the effects.

But real tumors behave differently than cancer cells in vitro, so Sood and his team extended their exciting findings into a mouse model of cancer. After receiving a transplant of ovarian cancer cells, mice were restrained to cause stress. As such, their tumors grow more quickly. Isoproterenol (a drug similar to adrenaline) had the same accelerative effect. The tumor-feeding effects of behaviorally and pharmacologically induced stress, both of which were mediated by FAK, were inhibited by the adrenaline-blocking drug propranolol.

###

By Katie Moisse

###

Stephanie Burns
.(JavaScript must be enabled to view this email address)
44-020-738-36920
BMJ-British Medical Journal

Page 2 of 21 2

Provided by ArmMed Media